Revisiting the Network of Drug-Eluting Stent Trials: Bioresorbable Scaffolds Enter the Arena.
Cardio-Thoracic-Vascular Department, Ferrarotto Hospital, University of Catania, Catania, Italy. Electronic address: dcapodanno@gmail.com.
Davide
D
Capodanno
D020341:Absorbable Implants; D054855:Drug-Eluting Stents; D000068338:Everolimus; D006801:Humans; D062645:Percutaneous Coronary Intervention; D054457:Tissue Scaffolds
D000068338:Everolimus
bioresorbable scaffold(s); drug-eluting stent(s); network meta-analysis